Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies.
暂无分享,去创建一个
Juan F. García | M. Piris | T. Marafioti | L. Maestre | D. Mason | R. Wieser | S. Montes-Moreno | A. Sanz | E. Lucas | G. Roncador | J. García | Rebeca Fernandez Victoria | Jorge L Martinez-Torrecuadrara | H. Pirc‐Danoewinata | Christa Fonatsch | H. Rieder | Ulrike Schreiner | Helga Grüner | Ivan F. Loncarevic
[1] R. Wieser,et al. Interphase fluorescence in situ hybridization assay for the detection of 3q21 rearrangements in myeloid malignancies , 2001, Genes, chromosomes & cancer.
[2] P. D. de Jong,et al. A bacterial artificial chromosome library for sequencing the complete human genome. , 2001, Genome research.
[3] J. Lehman,et al. Human cell line that differentiates to all myeloid lineages and expresses neutrophil secondary granule genes. , 2000, Experimental hematology.
[4] S. Schnittger,et al. Mapping of leukaemia‐associated breakpoints in chromosome band 3q21 using a newly established PAC contig , 2000, British journal of haematology.
[5] U. Jaeger,et al. Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26) , 2000, Annals of Hematology.
[6] K. Suzukawa,et al. Establishment of a novel human myeloid leukaemia cell line (HNT‐34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome , 1997, British journal of haematology.
[7] Y. Pekarsky,et al. Leukemia breakpoint region in 3q21 is gene rich. , 1997, Gene.
[8] J. Goldman,et al. Factors influencing the false positive and negative rates of BCR‐ABL fluorescence in situ hybridization , 1997, Genes, chromosomes & cancer.
[9] P. Marynen,et al. Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. , 1997, Cancer research.
[10] P. Marynen,et al. Fluorescence in situ hybridization analysis of t(3; 12)(q26; p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes. , 1996, Blood.
[11] H. Drexler,et al. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3. , 1996, Leukemia.
[12] H. Drexler,et al. Cohabiting t(12;22) and inv(3) primary rearrangements in an acute myelomonocytic leukemia (FAB M4) cell line , 1996 .
[13] B. Bain,et al. Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study , 1995, British journal of haematology.
[14] Y. Pekarsky,et al. Cloning of breakpoints in 3q21 associated with hematologic malignancy. , 1995, Cancer genetics and cytogenetics.
[15] R. Gascoyne,et al. Acute leukemia with structural rearrangements of chromosome 3. , 1995, Leukemia & lymphoma.
[16] J. Yokota,et al. Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26). , 1994, Blood.
[17] P. Greenberg,et al. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. , 1994, Blood.
[18] E. Thiel,et al. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26). , 1994, Leukemia.
[19] J. Rowley,et al. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Ihle,et al. DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome. , 1994, Blood.
[21] Y. Yazaki,et al. Generation of the AML1‐EVI‐1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. , 1994, The EMBO journal.
[22] J. Ihle,et al. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Berger,et al. Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region. , 1992, Leukemia.
[24] J. Ihle,et al. The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes. , 1990, Oncogene.
[25] C. Fonatsch,et al. Persistent Epstein‐Barr virus infection associated with monosomy 7 or chromosome 3 abnormality in childhood myeloproliferative disorders , 1985, British journal of haematology.
[26] P Berg,et al. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. , 1977, Journal of molecular biology.
[27] H. Drexler,et al. Cohabiting t(12;22) and inv(3) primary rearrangements in an acute myelomonocytic leukemia (FAB M4) cell line. , 1996, Genes, chromosomes & cancer.
[28] J. Winter,et al. t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. , 1990, Blood.